153
Participants
Start Date
February 28, 2013
Primary Completion Date
March 31, 2014
Study Completion Date
June 30, 2014
Sofosbuvir
Sofosbuvir 400 mg tablet administered orally once daily
RBV
Ribavirin (RBV) tablets were administered orally in a divided daily dose according to package insert weight-based dosing according to the approved Copegus labeling in Japan (\< 60 kg = 600 mg , \> 60 kg to ≤ 80 kg = 800 mg, and ≥ 80 kg = 1000 mg)
Akita
Chiba
Chiyoda-ku
Gifu
Ichikawa
Itabashi-ku
Izunokuni
Kita-ku
Kurashiki
Kurume
Matsumoto
Musashino
Nishinomiya
Ōgaki
Ōmura
Sapporo
Shinjuku-ku
Suita
Yamagata
Lead Sponsor
Gilead Sciences
INDUSTRY